Existing drug may slow progression of MS in ‘exciting’ world-first trial

news4health.gr

Factuality

Ownership

Alpha-lipoic acid has shown encouraging early results in the international Octopus study and is moving into phase two trials to test its effectiveness in protecting nerves and slowing the progression of the disease. An already available drug with antioxidant and anti-inflammatory properties may help slow the progression of multiple sclerosis (MS), according to early findings from an international clinical trial. The UK Multiple Sclerosis Society…